Business Editors/Health & Medical Writers
 
	   SARASOTA, Fla.--(BUSINESS WIRE)--Sept. 1, 2000--DNAPrint genomics,
Inc., (Pink Sheets:DNAP), a Sarasota, Florida based genomics
company, announced today that it has published its first scientific
paper, entitled "A Geometric Model of Information Retrieval Systems".
The paper, written by MyungHo Kim, Ph.D., was published in the Journal
of Complex Systems Volume 12, Number 1 p.93. The work outlines a
sophisticated approach for managing and mining complex information
using a model information dataset, and constitutes another important
step in the company's ambitious objectives.
	   Dr. Tony Frudakis said, "Until we have adequate analyst coverage,
we will continue to keep our investors informed of company milestones
through press releases. Our first publication is one such milestone.
Validation in peer-reviewed literature is an important way to
communicate and solidify relationships with potential partners within
the genomics industry, several of which we are currently negotiating."
 
About DNAPrint genomics
	   DNAPrint genomics, Inc. provides practitioners of genomic research
and personalized medicine with a comprehensive system for complex
trait dissection and patient classification. DNAPrint genomics Inc.
was founded by a group of scientists with research and commercial
experience in high-level mathematical modeling, programming and
molecular genetics. For more information about the company, please
visit www.dnaprint.com.
 
	   For scientific inquiries please contact: Dr. Tony Frudakis at
941/351-4543.
 
	   All other inquiries please contact: Richard Craig Hall at
941/341-0136.
 
	   Except for factual statements made herein, the information
contained in this press release consists of forward-looking statements
that involve risks and uncertainties. The Company's actual results
could differ materially from those contained in such statements.
Factors that could cause or contribute to such differences include
unexpected shortages of critical components, rescheduling or
cancellation of customer orders, the timing and market acceptance of
new product introductions by the Company and its competitors, and
general competition and price pressures in the marketplace.
 
    --30--law/mi*
 
    CONTACT:  DNAPrint genomics, Inc., Sarasota
              Scientific Inquiries:
              Dr. Tony Frudakis, 941/351-4543
              or
              All Other Inquiries:
              Richard Craig Hall, 941/341-0136